You are here » Home » Companies » Company Overview » Coral Laboratories Ltd

Coral Laboratories Ltd.

BSE: 524506 Sector: Health care
NSE: N.A. ISIN Code: INE683E01017
BSE LIVE 10:16 | 22 Nov 928.70 23.20
(2.56%)
OPEN

910.60

HIGH

928.70

LOW

905.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 910.60
PREVIOUS CLOSE 905.50
VOLUME 539
52-Week high 1190.00
52-Week low 566.00
P/E 19.66
Mkt Cap.(Rs cr) 332
Buy Price 905.00
Buy Qty 7.00
Sell Price 928.70
Sell Qty 10.00
OPEN 910.60
CLOSE 905.50
VOLUME 539
52-Week high 1190.00
52-Week low 566.00
P/E 19.66
Mkt Cap.(Rs cr) 332
Buy Price 905.00
Buy Qty 7.00
Sell Price 928.70
Sell Qty 10.00

Coral Laboratories Ltd. (CORALLABS) - Company History

Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated. During the year 1999-2000, the company has received ISO-9002 Certification.